Toxicity and Anti-feeding effect of Aesculushippocastanum, Thymus daenensis, Artemisia abrotanum, and Chrozophora tinctoria on Sitophillus oryzae

BACKGROUND AND AIM

The approach of food storage, especially cereals and basic human food sources, has long been considered as a problem to combat storage pests. the use of plant compounds has been suggested by researchers as an alternative to phosphine in the fight against pests.In this study, four plants such as Aesculushippocastanum, Thymus daenensis, Artemisia abrotanum and Chrozophoratinctoria were evaluated based on their deadly and repellent properties of pests and insectsconsidering Iranian medicine sources.

MATERIALS AND METHODS

First, plant extracts were prepared by ethanol solvent method and then, their lethal and Anti-feeding experiments were performed on rice insects (Sitophylusoryzae) in standard laboratory conditions.

RESULTS

Extracts of Thymus daenensis, Aesculushippocastanum, Artemisia abrotanum and Chrozophoratinctoria were estimated to be 553.2, 753.6, 878.3 and 987.3 mg / ml effective dose, respectively.The results showed that Thymus daenensis extract with 90.33% with lower concentration compared to Aesculushippocastanum, Artemisia abrotanum and Chrozophoratinctoria extracts has the highest lethal effect against S. oryzae. Also in Anti-feedingtest, Thymus daenensis extract showed the highest Anti-feedingeffect in comparison with Aesculushippocastanum, Artemisia abrotanum and Chrozophoratinctoria extracts, respectively.

CONCLUSIONS

The use of plants in the control against storage pests such as rice weevils will have favorable environmental results, human health and less storage is dangerous.

The Role of Hydroxychloroquine in COVID-19 Treatment: A Systematic Review and Meta-Analysis

Objective: A systematic review and meta-analysis was carried out to examine the role of hydroxychloroquine (HCQ) in the treatment of COVID-19. Methods: We performed a systematic search in PubMed, Scopus, Embase, Cochrane- Library, Web of Science, Google Scholar, and medRxiv pre-print databases using available MeSH terms for COVID-19 and hydroxychloroquine. Data from all studies that focused on the effectiveness of HCQ with or without the addition of azithromycin (AZM) in confirmed COVID-19 patients, which were published up to 12 September 2020, were collated for analysis using CMA v.2.2.064. Results: Our systematic review retrieved 41 studies. Among these, 37 studies including 45,913 participants fulfilled the criteria for subsequent meta-analysis. The data showed no significant difference in treatment efficacy between the HCQ and control groups (RR: 1.02, 95% CI, 0.81–1.27). Combination of HCQ with AZM also did not lead to improved treatment outcomes (RR: 1.26, 95% CI, 0.91–1.74). Furthermore, the mortality difference was not significant, neither in HCQ treatment group (RR: 0.86, 95% CI, 0.71–1.03) nor in HCQ plus AZM treatment group (RR: 1.28, 95% CI, 0.76–2.14) in comparison to controls. Meta-regression analysis showed that age was the factor that significantly affected mortality (P<0.00001). Conclusion: The meta-analysis found that there was no clinical benefit of using either HCQ by itself or in combination with AZM for the treatment of COVID-19 patients. Hence, it may be prudent for clinicians and researchers to focus on other therapeutic options that may show greater promise in this disease. Keywords: Azithromycin, coronavirus outbreaks, pandemic, SARS-CoV-2 disease

The Role of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis

OBJECTIVE

A systematic review and meta-analysis was carried out to examine the role of hydroxychloroquine (HCQ) in the treatment of COVID-19.

METHODS

We performed a systematic search in PubMed, Scopus, Embase, CochraneLibrary, Web of Science, Google Scholar, and medRxiv pre-print databases using available MeSH terms for COVID-19 and hydroxychloroquine. Data from all studies that focused on the effectiveness of HCQ with or without the addition of azithromycin (AZM) in confirmed COVID-19 patients, which were published up to 12 September 2020, were collated for analysis using CMA v.2.2.064.

RESULTS

Our systematic review retrieved 41 studies. Among these, 37 studies including 45,913 participants fulfilled the criteria for subsequent meta-analysis. The data showed no significant difference in treatment efficacy between the HCQ and control groups (RR: 1.02, 95% CI, 0.81-1.27). Combination of HCQ with AZM also did not lead to improved treatment outcomes (RR: 1.26, 95% CI, 0.91-1.74). Furthermore, the mortality difference was not significant, neither in HCQ treatment group (RR: 0.86, 95% CI, 0.71-1.03) nor in HCQ plus AZM treatment group (RR: 1.28, 95% CI, 0.76-2.14) in comparison to controls. Meta-regression analysis showed that age was the factor that significantly affected mortality (P<0.00001).

CONCLUSION

The meta-analysis found that there was no clinical benefit of using either HCQ by itself or in combination with AZM for the treatment of COVID-19 patients. Hence, it may be prudent for clinicians and researchers to focus on other therapeutic options that may show greater promise in this disease.

Calculating fluoride concentrations data using ambient temperatures in drinking water distribution networks in select provinces of Iran

Fluoride concentrations in drinking water were analyzed relative to air temperature data collected in different provinces of Iran. Determining suitable concentrations of fluoride in drinking water is crucial for communities because of the health effects of fluoride on humans. This study analyzed fluoride concentrations in drinking water from selected Iranian provinces. The data were derived mainly from a detailed literature review. The annual mean maximum temperatures (AMMTs) were collected from a popular website that maintains records of daily ambient temperature measurements for the last five years (2012-2016). Using regional ambient temperatures, the optimal value of fluoride in drinking water for each province was calculated by the Galgan and Vermillion formula. These optimal fluoride concentrations in drinking water for different Iranian regions were calculated to be 0.64-1.04 mg F/L. Most of the selected provinces were found to have acceptable concentrations of fluoride, except for Alborz, Khuzestan, and Hormozgan, which reported concentrations of 0.66, 0.66, and 0.64 mg/L, respectively.